Journal of Substance Abuse Treatment
Volume 31, Issue 4 , Pages 385-393 , December 2006

A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model

  • Van L. King, M.D.

      Affiliations

    • The Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, MD, USA
    • Corresponding Author InformationCorresponding author. Addiction Treatment Services, Johns Hopkins Bayview Medical Center, 5510 Nathan Shock Drive, Suite 1500, Baltimore, MD 21224, USA. Tel.: +1 410 550 0146.
    • ,
  • Michael S. Kidorf, Ph.D.

      Affiliations

    • The Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, MD, USA
    • ,
  • Kenneth B. Stoller, M.D.

      Affiliations

    • The Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, MD, USA
    • ,
  • Robert Schwartz, M.D.

      Affiliations

    • Friends Research Institute, Baltimore, MD, USA
    • Open Society Institute, Baltimore, MD, USA
    • ,
  • Kenneth Kolodner, Sc.D.

      Affiliations

    • The Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, MD, USA
    • ,
  • Robert K. Brooner, Ph.D.

      Affiliations

    • The Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, MD, USA

Received 16 February 2006 ,Revised 27 April 2006 ,Accepted 14 May 2006.

References 

  1. Brooner RK, Kidorf MS. Using behavioral reinforcement to improve methadone treatment outcomes. Science Practice and Perspectives. 2002;1:38–48
  2. Brooner RK, Kidorf MS, King VL, Stoller KB, Peirce JM, Bigelow GE, et al. Behavioral contingencies improve counseling attendance in an adaptive treatment model. Journal of Substance Abuse Treatment. 2004;27:223–232
  3. Center for Substance Abuse Research (CESAR). (2003). Maryland methadone overdose deaths increase ten-fold since 1997. CESAR FAX, 12 (Feb. 17).
  4. Center for Substance Abuse Treatment . Methadone-associated mortality: Report of a national assessment, May 8–9, 2003. SAMHSA Publication No. 04-3904 Rockville, MD: Center for Substance Abuse Treatment: Substance Abuse and Mental Health Administration; 2004;
  5. Chutuape MA, Silverman K, Stitzer ML. Effects of urine testing frequency on outcome in a methadone take-home contingency program. Drug and Alcohol Dependence. 2001;62:69–76
  6. Davison GC. Stepped care: Doing more with less?. Journal of Consulting and Clinical Psychology. 2000;68:580–585
  7. Des Jarlais DC, Joseph H, Dole VP, Nyswander ME. Medical maintenance feasibility study. In:  Asbery RS editors. Progress in the development of cost–effective treatment for drug abusers. Research monograph. 58:Rockville, MD: NIDA; 1985;p. 101–111
  8. Drug Early Warning System (DEWS) . DEWS investigates: What is behind the rise in methadone deaths in Maryland?. College Park, MD: Center for Substance Abuse Research; 2004, May;
  9. Farabee D, Rawson R, McCann M. Adoption of drug avoidance activities among patients in contingency management and cognitive–behavioral treatments. Journal of Substance Abuse Treatment. 2002;23:343–350
  10. Fiellin DA, O'Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Methadone maintenance in primary care: A randomized controlled trial. JAMA. 2001;286:1724–1731
  11. King VL, Stoller KB, Hayes M, Umbricht A, Curran M, Kidorf MS, et al. A multicenter randomized evaluation of methadone medical maintenance. Drug and Alcohol Dependence. 2002;65:137–148
  12. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning. 1979;2:197–207
  13. Luborsky L, Barber JP, Siqueland L, Najavits LM, Frank A, Daley D. The Revised Helping Alliance Questionnaire (HAq-II): Psychometric properties. Journal of Psychotherapy Practice and Research. 1996;5:260–271
  14. Marsch LA, Stephens MAC, Mudric T, Strain E, Bigelow G, Johnson R. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Experimental and Clinical Psychopharmacology. 2005;13:293–302
  15. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992;9:199–213
  16. Miller WR. Researching the spiritual dimensions of alcohol and other drug problems. Addiction. 1998;93:979–990
  17. Novick DM, Joseph H, Salsitz EA, Kalin MF, Keefe JB, Miller EL, et al. Outcomes of treatment of socially rehabilitated methadone maintenance patients in physician's offices (medical maintenance): Follow-up at three and a half to nine and a fourth years. Journal of General Internal Medicine. 1994;9:127–130
  18. Platt JJ. Vocational rehabilitation of drug abusers. Psychological Bulletin. 1995;117:416–433
  19. Salsitz EA, Joseph H, Frank B, Perez J, Richman BL, Salomon N, et al. Methadone medical maintenance (MMM): Treating chronic opioid dependence in private medical practice—A summary report (1983–1998). Mount Sinai Journal of Medicine. 2000;67:388–397
  20. Schwartz RP, Brooner RK, Montoya ID, Currans M, Hayes M. A 12-year follow-up of a methadone medical maintenance program. American Journal on Addictions. 1999;8:293–299
  21. Senay EC, Barthwell AG, Marks R, Bokos P, Gillman D, White R. Medical maintenance: A pilot study. Journal of Addictive Diseases. 1993;12:59–77
  22. Sobell MB, Sobell LC. Stepped care as a heuristic approach to the treatment of alcohol problems. Journal of Consulting and Clinical Psychology. 2000;68:573–579
  23. Wasserman DA, Stewart AL, Delucchi KL. Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug and Alcohol Dependence. 2001;65:65–75

PII: S0740-5472(06)00154-1

doi: 10.1016/j.jsat.2006.05.014

Journal of Substance Abuse Treatment
Volume 31, Issue 4 , Pages 385-393 , December 2006

Article Tools

* Image Usage & Resolution